Neuroscience
Multiple Sclerosis
100%
Blood Plasma
27%
Cerebrovascular Accident
27%
Brain Ischemia
23%
Relapsing Remitting Multiple Sclerosis
22%
Microglia
20%
Myelin
19%
Oligodendrocyte
18%
Magnetic Resonance Imaging
16%
Proteome
16%
Auras
14%
Migraine
14%
T Cell
14%
Neurofilament Light Chain
14%
Tumor Necrosis Factor Receptor 2
14%
Magnetic Resonance Imaging
13%
Expanded Disability Status Scale
12%
Randomized Controlled Trial
11%
Neurofilament
11%
Necrosis
10%
Nerve Fiber Degeneration
10%
Axonal Degeneration
10%
Interleukin 1
9%
Neuromyelitis Optica
9%
Teriflunomide
9%
Ischemia
9%
Messenger RNA
9%
Central Nervous System
8%
Neuropsychological Test
8%
Secondary Progressive Multiple Sclerosis
8%
Interleukin 8
7%
Neuroprotective Agent
6%
Remyelinization
6%
Ocrelizumab
6%
Alemtuzumab
6%
Leukocyte
6%
Placebo
5%
Transcriptome
5%
Tamsulosin
5%
Cognitive Tests
5%
Neuroprotection
5%
Cognitive Disorders
5%
Magnetic Resonance Imaging of Brain
5%
Medicine and Dentistry
Multiple Sclerosis
47%
Quality of Life
18%
Myelin
11%
Migraine with Aura
9%
Teriflunomide
9%
Aerobic Exercise
9%
T Cell
9%
Neuromyelitis Optica
9%
Recurrence Risk
7%
Oligodendrocyte
6%
Magnetic Resonance Imaging
6%
Neurology
6%
Central Nervous System
6%
Magnetic Resonance Imaging of Brain
6%
Prevalence
5%
Adverse Event
5%
Migraine
5%
Biological Marker
5%
Aquaporin 4 Antibody
5%
Diseases
5%
Randomized Controlled Trial
5%
Pediatrics
5%
Observational Study
5%
Expanded Disability Status Scale
5%
Immunology and Microbiology
Neuromyelitis Optica
23%
Multiple Sclerosis
23%
Cerebrospinal Fluid
19%
Central Nervous System
10%
Blood Plasma
7%
Myelin
6%
Immune Response
6%
Tumor Necrosis Factor Receptor 2
6%
Remyelinization
5%
Dynamics
5%
Aquaporin 4 Antibody
5%